Available Today!

We’re pleased to introduce LATISSE (bimatoprost ophthalmic solution) 0.03% - the first and only  FDA-approved prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker, and darker.

Unretouched photos of LATISSE  users in the clinical trial before starting treatment and at week 16. The onset of effect with LATISSE™ solution is gradual. In the clinical trial, the majority of users saw significant improvement by 2 months. Individual results may vary.

Come in today for the newest innovation in lashes.

LATISSE™ has been studied in clinical trials to demonstrate its safety and effectiveness. To see more results or learn more, visit www.latisse.com

Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.

>  Latisse FDA Release  <